Waist circumference, body mass index, and their association with cardiometabolic and global risk

Journal of the CardioMetabolic Syndrome

Volumn 4, Issue 1, 2009, Pages 12-19

  Christian, Allison H ^a   Mochari, Heidi ^a   Mosca, Lori J ^a,b  

^a Howard Hughes Medical Institute   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPASE A2; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY FAT; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ENZYME BLOOD LEVEL; ETHNICITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRACTICE GUIDELINE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RACE DIFFERENCE; RISK ASSESSMENT; SCREENING TEST; TISSUE DISTRIBUTION; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

BLOOD GLUCOSE; BLOOD PRESSURE; BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CONTINENTAL POPULATION GROUPS; CORONARY DISEASE; FEMALE; HUMANS; MALE; METABOLIC DISEASES; MIDDLE AGED; OBESITY; PHOSPHOLIPASES A2; RISK FACTORS; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 61349197673     PISSN: 15594564     EISSN: 15594572     Source Type: Journal    
DOI: 10.1111/j.1559-4572.2008.00029.x     Document Type: Article

References (36)

1. Hedley AA, Ogden CL, Johnson CL, et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA. 2004;291:2847-2850.
2. Lear SA, Toma M, Birmingham L, et al. Modification of the relationship between simple anthropometric indices and risk factors by ethnic backgrounds. Metabolism. 2003;52:1295-1301.
3. Kennel WB, Cupples LA, Ramaswami R, et al. Regional obesity and risk of cardiovascular disease; the Framingham Study. J Clin Epidemiol 1991;44:183-190.
4. Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med. 1990;322:882-889.
5. Jousilahti P, Toumilehto J, Vartiainen E, et al. Body weight, cardiovascular risk factors, and coronary mortality. 15-year follow-up of middle-aged men and women in eastern Finland. Circulation. 1996;93:1372-1379.
6. Nicklas BJ, Penninx BW, Cesari M, et al. Association of visceral adipose tissue with incident myocardial infarction in older men and women: The Health, Aging, and Body Composition Study. Am J Epidemiol 2004;160:741-749.
7. Ho SC, Chen YM, Woo JLF, et al. Association between simple anthropometric indices and cardiovascular risk factors. Int J Obes. 2001;25:1689-1697.
8. Onat A, Avci GS, Uyarel H, et al. Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk. Int J Obes. 2004;28:1018-1025.
9. World Health Organization. Obesity - Preventing and Managing the Global Epidemic: Report of a WHO Consultation on Obesity. Geneva: World Health Organization; 1998.
10. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-3421.
11. National Health Institutes. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: Executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Am J Clin Nutr 1998;68:899-917.
12. Moreira-Andres MN, del Canizo-Gomez FJ, Losa MA, et al. Comparison of anthropometric parameters as predictors of serum lipids in premenopausal women. J Endocrinol Invest. 2004;27:340-347.
13. Mosca L, Mochari H, Liao M, et al. A novel family-based intervention trial to improve heart health: Results of a randomized controlled trial. Circ Cardiovasc Quality Outcomes. 2008;1:98-106.
14. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252.
15. Mosca L, Appel LJ, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation. 2004;109:672-693.
16. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2006;29:S43-S48.
17. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association. Circulation. 2003;107:499-511.
18. Bahceci M, Gokalp D, Bahceci S, et al. The correlation between adiposity and adiponectin, tumor necrosis factor alpha, interleukin-6 and high sensitivity C-reactive protein levels. Is adipocyte size associated with inflammation in adults? J Endocrinol Invest. 2007;30:210-214.
19. Khaodhiar L, Ling PR, Blackburn GL, et al. Serum levels of interleukin-6 and C-reactive protein correlate with body mass index across the broad range of obesity. JPEN J Parenter Enteral Nutr 2004;28:410-415.
20. Kriketos AD, Greenfield JR, Peake PW, et al. Inflammation, insulin resistance, and adiposity: A study of first-degree relatives of type 2 diabetic subjects. Diabetes Care. 2004;27:2033-2040.
21. Festa A, D'Agostino R Jr, Williams K, et al. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 2001;25:1407-1415.
22. Albert MA, Glynn RJ, Ridker PM. Plasma concentration of c-reactive protein and the calculated Framingham coronary heart disease risk score. Circulation. 2003;108:161-165.
23. Rogowski O, Shapira I, Toker S, et al. Obesity-related correlation between c-reactive protein and the calculated 10-y Framingham coronary heart disease risk score. Int J Obes. 2005;29:772-777.
24. Lopatynski J, Mardarowicz G, Szczesniak G. A comparative evaluation of waist circumference, waist-to-hip ratio, waist-to-height ratio and body mass index as indicators of impaired glucose tolerance and as risk factors for type-2 diabetes mellitus. Ann Univ Mariae Curie Sklodowska. 2003;58:413-419.
25. Bosy-Westphal A, Geisler C, Onur S, et al. Value of body fat mass vs anthropometric obesity indices in the assessment of metabolic risk factors. Int J Obes. 2006;30:475-483.
26. Shen W, Punyanitya M, Chen J, et al. Waist circumference correlates with metabolic syndrome indicators better than percentage fat. Obesity. 2006;14:727-736.
27. Sung KC, Ryu SH. Insulin resistance, body mass index, waist circumference are independent risk factor for high blood pressure. Clin Exp Hypertens. 2004;26:547-556.
28. Weinbrenner T, Schroder H, Escurriol V, et al. Circulating oxidized LDL is associated with increased waist circumference independent of body mass index in men and women. Am J Clin Nutr 2006;83:30-35.
29. Mosca L, Edelman D, Mochari H, et al. Waist circumference predicts cardiometabolic risk among women screened during national women's heart day. J Womens Health. 2006;15:24-34.
30. Kato MM, Currier MB, Villaverde O, et al. The relationship between body fat distribution and cardiovascular risk factors in patients with schizophrenia: A cross-sectional pilot study. Prim Care Companion J Clin Psychiatry. 2005;7:115-120.
31. Smith DA, Ness EM, Herbert R, et al. Abdominal diameter index: A more powerful anthropometric measure for prevalent coronary heart disease risk in adult males. Keabetes Obes Metab. 2005;7:370-380.
32. Tanko LB, Bagger YZ, Qin G, et al. Enlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogensis and related cardiovascular mortality in postmenopausal women. Circulation. 2005;111:1883-1890.
33. Cassidy AE, Bielak LF, Zhou Y, et al. Progression of subclinical coronary atherosclerosis. Does obesity make a difference? Circulation. 2005;111:1877-1882.
34. Freudenheim JL, Darrow SL. Accuracy of self-measurement of body fat distribution by waist, hip, and thigh circumferences. Nutr Cancer 1991;15:179-186.
35. Spencer EA, Roddam AW, Key TJ. Accuracy of self-reported waist and hip measurements. Public Health Nutr. 2004;7:723-727.
36. Rimm EB, Stampfer MJ, Colditz GA, et al. Validity of self-reported waist and hip circumferences in men and women. Epidemiology. 1990;1:466-473.